Sildenafil
Product Images NDC 50090-3082

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-3082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-7.jpg (Graph1)

FDA Label Image

Image-1.jpg (Image 1)

FDA Label Image

Image-2.jpg (Image 2)

FDA Label Image

Image-3.jpg (Image 3)

FDA Label Image

Image-4.jpg (Image 4)

FDA Label Image

Image-5.jpg (Image 5)

Image-5.jpg (Image 5)
This appears to be a table displaying different medications and their corresponding dosing adjustments or recommendations based on their AUC and other factors. It also includes a note about the lack of benefit on exercise capacity when sildenafil is added to bosentan therapy, as well as a recommended vertical solid line on the table.*
FDA Label Image

Image-6.jpg (Image 6)

Image-6.jpg (Image 6)
The text appears to be a table showing the drug interactions and recommended fold change for various drugs. The table includes drug names such as Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. There are also mentions of INR, AUC, Cmax, and dose adjustment. Overall, it seems to be a reference guide for healthcare professionals on how to adjust dosages when combining these drugs to avoid negative drug interactions.*
FDA Label Image

Label Image (Lbl500903082)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.